Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide, contributing to approximately 20% of total maternal deaths.1 The gold standard uterotonic agent, oxytocin, has been shown to reduce the risk of PPH by 50% and is recommended by the WHO for administration via intravenous or intramuscular injection to every woman during the third stage of labour for the prevention of PPH.2 3. Here, OXT is linked to postpartum hemorrhage.